A Review of Twenty Years of Research on the Regulation of Signaling Pathways by Natural Products in Breast Cancer
Authors:
- Muhammad NaeemMuhammad Naeem
- Muhammad Omer IqbalMIMuhammad Omer Iqbal
- Humaira KhanHKHumaira Khan
- Muhammad Masood AhmedMAMuhammad Masood Ahmed
- Muhammad FarooqMuhammad Farooq
- Muhammad Moeen AadilMAMuhammad Moeen Aadil
- Mohamad Ikhwan JamaludinMohamad Ikhwan Jamaludin
- Abu HazafaAbu Hazafa
- Wan-Chi TsaiWan-Chi Tsai
Open Access
Abstract
Breast cancer (BC) is the second leading cause of death among women, and it has become a global health issue due to the increasing number of cases. Different treatment options, including radiotherapy, surgery, chemotherapy and anti-estrogen therapy, aromatase inhibitors, anti-angiogenesis drugs, and anthracyclines, are available for BC treatment. However, due to its high occurrence and disease progression, effective therapeutic options for metastatic BC are still lacking. Considering this scenario, there is an urgent need for an effective therapeutic strategy to meet the current challenges of BC. Natural products have been screened as anticancer agents as they are cost-effective, possess low toxicity and fewer side effects, and are considered alternative therapeutic options for BC therapy. Natural products showed anticancer activities against BC through the inhibition of angiogenesis, cell migrations, proliferations, and tumor growth; cell cycle arrest by inducing apoptosis and cell death, the downstream regulation of signaling pathways (such as Notch, NF-κB, PI3K/Akt/mTOR, MAPK/ERK, and NFAT-MDM2), and the regulation of EMT processes. Natural products also acted synergistically to overcome the drug resistance issue, thus improving their efficacy as an emerging therapeutic option for BC therapy. This review focused on the emerging roles of novel natural products and derived bioactive compounds as therapeutic agents against BC. The present review also discussed the mechanism of action through signaling pathways and the synergistic approach of natural compounds to improve their efficacy. We discussed the recent in vivo and in vitro studies for exploring the overexpression of oncogenes in the case of BC and the current status of newly discovered natural products in clinical investigations.Keywords
Funding Information
- nsysu-kmu joint research project (NSYSUKMU 111-I06, KMU-M111009)
- Kaohsiung Medical University Research Foundation (NSYSUKMU 111-I06, KMU-M111009)
This publication has 183 references indexed in Scilit:
- Natural Product Ginsenoside 25-OCH3-PPD Inhibits Breast Cancer Growth and Metastasis through Down-Regulating MDM2PLOS ONE, 2012
- Breast Cancer Chemoprevention: Old and New ApproachesJournal of Biomedicine and Biotechnology, 2012
- Trans-Resveratrol Alters Mammary Promoter Hypermethylation in Women at Increased Risk for Breast CancerNutrition and Cancer, 2012
- Delphinidin Inhibits HER2 and Erk1/2 Signaling and Suppresses Growth of HER2-Overexpressing and Triple Negative Breast Cancer Cell LinesBreast Cancer: Basic and Clinical Research, 2011
- Skin photoprotection by natural polyphenols: anti-inflammatory, antioxidant and DNA repair mechanismsArchives of Dermatological Research, 2009
- Targeting the phosphoinositide 3-kinase pathway in cancerNature Reviews Drug Discovery, 2009
- Cancer-related inflammation, the seventh hallmark of cancer: links to genetic instabilityCarcinogenesis, 2009
- Newly discovered breast cancer susceptibility loci on 3p24 and 17q23.2Nature Genetics, 2009
- Potential therapeutic effects of curcumin, the anti-inflammatory agent, against neurodegenerative, cardiovascular, pulmonary, metabolic, autoimmune and neoplastic diseasesThe International Journal of Biochemistry & Cell Biology, 2009
- Growth inhibitory activity of extracts and compounds from Cimicifuga species on human breast cancer cellsPhytomedicine, 2008